FIGURE

Figure 4

ID

ZDB-FIG-220407-4

Publication

Arslan et al., 2022 - Effect of non-repetitive linker on in vitro and in vivo properties of an anti-VEGF scFv

Other Figures

All Figure Page

Back to All Figure Page

Figure 4

In vivo angiogenesis inhibition by L1, L2 and bevacizumab. (A) Lateral view of subintestinal vessels (SIVs) in fli1:EGFP transgenic zebrafish larvae at 3 dpf. (B) PBS (negative control) (C) 27.5 μM bevacizumab (D) 55 μM L1, (E) 55 μM L2 were injected into yolk of 2 dpf fli1:EGFP transgenic zebrafish embryos. At 3 dpf, zebrafish SIVs were imaged by confocal microscopy. (F) Percentages of average SIV areas were quantified. The outcomes are expressed as AVG ± SD. n_PBS = 25, n_bevacizumab = 24, n_L1 = 24, n_L2 = 23. Statistical analysis was performed using one-tail t-test. Statistical results: n.s. p > 0.05, ****p < 0.0001.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Sci. Rep.